Fisher & Paykel Healthcare Corporation Ltd - Asset Resilience Ratio
Fisher & Paykel Healthcare Corporation Ltd (FPH) has an Asset Resilience Ratio of 0.02% as of March 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2003–2023)
This chart shows how Fisher & Paykel Healthcare Corporation Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Fisher & Paykel Healthcare Corporation Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$500.00K | 0.02% |
| Total Liquid Assets | AU$500.00K | 0.02% |
Asset Resilience Insights
- Limited Liquidity: Fisher & Paykel Healthcare Corporation Ltd maintains only 0.02% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Fisher & Paykel Healthcare Corporation Ltd Industry Peers by Asset Resilience Ratio
Compare Fisher & Paykel Healthcare Corporation Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Unicon Optical Co., Ltd.
TWO:4150 |
Medical Instruments & Supplies | 2.00% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931 |
Medical Instruments & Supplies | 0.06% |
|
Blue Sail Medical Co Ltd
SHE:002382 |
Medical Instruments & Supplies | 5.12% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 35.75% |
|
Allmed Medical Products Co Ltd Class A
SHE:002950 |
Medical Instruments & Supplies | 3.78% |
|
Inix Technologies Holdings Bhd
KLSE:0094 |
Medical Instruments & Supplies | 0.06% |
|
Focus Point Holdings Bhd
KLSE:0157 |
Medical Instruments & Supplies | 2.30% |
Annual Asset Resilience Ratio for Fisher & Paykel Healthcare Corporation Ltd (2003–2023)
The table below shows the annual Asset Resilience Ratio data for Fisher & Paykel Healthcare Corporation Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-03-31 | 0.02% | AU$500.00K | AU$2.06 Billion | -10.22pp |
| 2022-03-31 | 10.25% | AU$200.00 Million | AU$1.95 Billion | -3.26pp |
| 2021-03-31 | 13.51% | AU$257.74 Million | AU$1.91 Billion | +8.09pp |
| 2020-03-31 | 5.41% | AU$75.26 Million | AU$1.39 Billion | -2.25pp |
| 2019-03-31 | 7.67% | AU$88.81 Million | AU$1.16 Billion | -3.96pp |
| 2018-03-31 | 11.63% | AU$112.10 Million | AU$964.08 Million | +9.22pp |
| 2017-03-31 | 2.41% | AU$19.40 Million | AU$804.74 Million | +0.74pp |
| 2016-03-31 | 1.67% | AU$11.55 Million | AU$692.09 Million | -1.88pp |
| 2015-03-31 | 3.55% | AU$23.78 Million | AU$669.82 Million | -1.71pp |
| 2014-03-31 | 5.26% | AU$33.14 Million | AU$630.33 Million | +0.67pp |
| 2013-03-31 | 4.58% | AU$28.36 Million | AU$618.60 Million | +0.90pp |
| 2012-03-31 | 3.68% | AU$21.05 Million | AU$572.05 Million | +0.81pp |
| 2011-03-31 | 2.87% | AU$14.87 Million | AU$517.61 Million | -1.64pp |
| 2010-03-31 | 4.51% | AU$21.44 Million | AU$475.06 Million | +3.00pp |
| 2009-03-31 | 1.51% | AU$6.26 Million | AU$413.74 Million | +0.65pp |
| 2008-03-31 | 0.86% | AU$2.86 Million | AU$331.67 Million | -3.62pp |
| 2006-03-31 | 4.49% | AU$12.00 Million | AU$267.47 Million | -1.59pp |
| 2005-03-31 | 6.08% | AU$14.00 Million | AU$230.31 Million | -1.50pp |
| 2004-03-31 | 7.58% | AU$17.00 Million | AU$224.17 Million | -7.72pp |
| 2003-03-31 | 15.30% | AU$35.00 Million | AU$228.75 Million | -- |
About Fisher & Paykel Healthcare Corporation Ltd
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The com… Read more